TABLE 2.

Primers^a

Target	Forward primer (5′–3′)	HBV positions (genotype C)	Reverse primer (5′–3′)	HBV positions (genotype C)
Analysis of ChIP samples
Actin TSS	TAG AAG TCG CAG GAC CAC ACT	NA	TGG GTA GGT TTG TAG CCT TCA T	NA
Nanog TSS	TGG GTT TGT CTT CAG GTT CTG	NA	CTA CTG ACC CAC CCT TGT GAA	NA
Sat2	CAT CGA ATG GAA ATG AAA GGA GTC	NA	ACC ATT GGA TGA TTG CAG TCA A	NA
HBV_1	TTA ACA GGC CTA TTG ATT GGA AA	965–984	TCA ACG CAG GAT AAC CAC ATT	1034–1049
DNA quantification
HBV-DNA	CCA AAA TTC GCA GTC CCC AAC	304–324	GAG GCA TAG CAG CAG GAT GAA G	406–427
RNA quantification
pgRNA	GAG TGT GGA TTC GCA CTC CTC	2268–2288	CGA GGC GAG GGA GTT CTT CT	2378–2397
pg/S-RNA	CCC GTT TGT CCT CTA ATT CC	467–486	GTC CGA AGG TTT GGT ACA GC	567–585
HBV-RNA	GTG CAC TTC GCT TCA CCT CT	1579–1598	TTG ACA TTG CTG AGA GTC CAA	1666–1686
IMAP	TTT TCA GCT CCC AAG TGT CC	NA	GCC GAG AGC AGG TAG CAG T	NA

^aHBV primer positions are according to a well-annotated HBV genome (GenBank accession number AM282986) of genotype A (56). IMAP, immunity-associated protein; TSS, transcriptional start site; NA, not applicable.